CLAIRE DRUMMOND: Open Payments
NPI 1881848877 · GONZALES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,157 in 122 payments from 22 companies in 2025. Trend: 2023 $2,119 · 2024 $2,115 · 2025 $2,157
Food & beverage: $2,157
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $355 |
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $284 |
| Axsome Therapeutics, Inc. | 7 | $234 |
| Astellas Pharma US Inc | 10 | $157 |
| Antares Pharma, Inc. | 7 | $137 |
| GlaxoSmithKline, LLC. | 8 | $135 |
| Corcept Therapeutics | 1 | $126 |
| Collegium Pharmaceutical, Inc. | 8 | $120 |
| Lilly USA, LLC | 6 | $109 |
| Abbott Laboratories | 4 | $93 |
Products named: Kerendia, Auvelity, Veozah, XYOSTED, QULIPTA, Korlym, UBRELVY, Belbuca.
Industry payments across LA — which companies pay providers there.
